Validation of a Screening Method for Dynamic Mutations in the FMR1 Gene

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Fragile X syndrome is caused by dynamic mutations, specifically CGG repeat expansions, in the FMR1 gene.
• Accurate determination of these repeat numbers is crucial for diagnosis and carrier screening.
• Existing methods like Southern blot analysis can be time-consuming and complex.

Purpose of the Study:

• To validate the direct triplet-primed PCR (dTP-PCR) method for quantifying CGG repeats in the FMR1 gene.
• To compare the diagnostic performance of dTP-PCR with Southern blot analysis.
• To assess the utility of dTP-PCR for population screening and identifying carriers of FMR1 gene mutations.

Main Methods:

• Direct triplet-primed PCR (dTP-PCR) was employed to determine the number of CGG repeats in the FMR1 gene.
• Melting curve analysis was utilized in conjunction with dTP-PCR for repeat quantification.
• A cut-off temperature was established using control samples to differentiate normal alleles from expanded permutations.
• Patient samples were categorized into four groups based on DNA melting curve profiles.

Main Results:

• The dTP-PCR method demonstrated high clinical performance with 100% sensitivity and 90.48% specificity in detecting CGG repeat expansions (>30) in the FMR1 gene.
• The assay successfully classified patients into distinct categories based on CGG repeat numbers.
• Results from dTP-PCR showed strong agreement with Southern blot analysis (implied by comparison objective).

Conclusions:

• The direct triplet-primed PCR (dTP-PCR) method is a validated and effective tool for determining dynamic mutations in the FMR1 gene.
• dTP-PCR provides a rapid and accurate alternative for screening populations and identifying individuals with FMR1 gene premutations or mutations.
• This method is particularly valuable for diagnosing intellectual disabilities of unknown etiology by identifying potential carriers.